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The inhence dmutdvfsel earana~ rrlrry disease on the 
outcmne of reprrfusinn therapy for myocardint infarction 
has not hem My ehararterired. Dirert cnmnar~ angio. 
plarty without antecedent thrombulytic therapy ws prr- 
formed during evolving myocardial inlarctiun ial 285 pa- 
tients with muttiwsset ~oronarv ertw disease at 5.2 + 
i43%1. An arkor inlaret *as present in 123 patients 
(43~),cardi~enieshorkinUtlZ~lande~e r70)earsin 
59 In%). 
Angiophxly of the infarct-related vessel was wcfs~fuI 
in 256 patierdr (96%). including 92% with two vasrl and 
88% wtth three vosset disease tp = NSI. Emergency b!pas 
surgery WI needed in six patients (ZckI. In-hospital death 
oreerred in 33 patients (12%). including 13 with two veuel 
and 20 with thm vessel disease tp < 0.051. The mortality 
rate was only 4% in the wbplroup of 101 patients who met 
not in she& \p C O.Oil. Lqirtic rqrei*ion analy& ida!- 
tificd shock and ape 570 yeen as independently arwciated 
nith in4mrpitat death. 
In 135 patients ahe underwent predireharge left ten. 
triculagraph~. p;lobat ejectian fraction inrrearrd kern 50% 
to 57% lo _; 0.001~ and regional wilt melien in the i&ret 
done improred in 59’1 al patieot~. Follow-up data were 
arailaSte in 251 patients I9991 at a mean of 35 * 19 
monthr. The actuarial 1 and 3 )ear rurvhat rate was 92% 
and 87%, respectively. and was rignifirantly better at bath 
intervals in patients with two russet direax (p < O.OOtL 
Thus. wimarr aneio~tastv in ntients nitb acute myo- 
cardiat ink& an6 &lti&l‘dianse results in a high 
reperhsion rzte. exeetlent bospitai survival. particularly in 
patients net in rhwk. and a favorable long4erm ontemne. 
(J Am CoN Car&l 1990;16:1089-96) 
In the majority of unselected patients presenting with acute 
myocardial infarction. the underlying anatomic soh\trate is 
multivessel coronary artery disease (I-61. In amdie* preccd- 
ing the current reperfubion era Q.44. the number of 
diseased coronary vessels was identified as one of the mo\t 
powerful predictors uf prognosis afwr acute myacxdlal 
infarction. Over the past decade. thempy for acute m)ocar- 
dial infarction has changed dramatically. and pharmacologic 
md mech;mc;d rtrategies of myocardial ,eperfwon are 
belo8 wed to ulvnpe iachemic myocardium and reduce the 
morlnlity rate 19-I I). However. the importance of muluves- 
ael coronary artery disease in dewmmming the hospital 
cnurw dnd long.term outcome after revascularization for 
acute myowrdul infarction has not heen fully characterired. 
Smce IYXI. o”r approach to the treatment of aculc 
myowrdisl Infarction has been immediate coronary arteri- 
ography. followed by primary coronary angioplasty of the 
infarct-related vessel without antecedent thrombolytic lber- 
apy. We previously reported our experience in X4 patients 
t I II .md rumined the subgroup with single vessel coronary 
artery dwa\s in detail (I?]. The purpose of the present 
rep03 I wa\ to examine the Bciur> islatcd to the lmmedlate 
outcome ;ind long-term rewks of lhis reperfusion strategy in 
pat~enr\ wlh underlying mullivewzl coronar) artery dis- 
ea\e. 
Methods 
Study pstients. Between 1981 and 1988.5OO patients with 
acute myocardial infarction were treated with direct co%- 
nary angioplasty without antecedent thmmbol)tic therapy. 
.lhts report examtncs the 285 patients determined to have 
multivessel coronary artery disease by coronary arteriogra- 
phy. Multivessel coronary artery disease was considered to 
be prevent when, in addition to the none of occlusion in the 
infarct-related veb~el. there was luminal narrowing of 270% 
diameter stenosis in onr or both of the other epicardial 
coronary aneries or their major branches. 
Clinical rrircriu for idmhn in I/W smdy wrc I) chest 
pain consistent with ongoing myocardial ischemia persisting 
230 min. 2) rl mm of ST segment elevation in two or more 
contiguous electrocardiographic (ECG) leads. and 3) in- 
formed consent from the patient or the patient’s family, or 
both. for study participation. Patients were excluded from 
the study for lhe following reasons: 1) treatment with a 
thrombolytic agent for the infarction in progress. 21 myocar- 
dial infarction resubing from acttte occlusion after coronary 
angioplasty or angiography. and 3) presentation to the emer- 
gency room >6 h after the onset of chest pain without 
clinical and ECG evidence of ongoing myocardial ischemia. 
Fifty-six patients (20%) with ongoing chest discomfort and 
preservation of R waves in the infarct region presenting 
>6 h but ~24 h after the onsct of chest oain were included. 
No patient was excluded for advanced age. prior myncardial 
infarction or coronary bypass surgery. clinical heart failure 
or cardiogcnic shock. hypertension or prior stroke. 
Angioplarty protocol. An emergency cardiac catheterira- 
lion team was on call 24 h a day. The acute procedure was 
generally begun within 30 to 45 mitt of notification. Invasive 
cardiologists with extensive experience in coronary angio- 
plasty performed the procedures. 
catheterization- ladoratory. patients received heparin 
(lO.tIlO U) and aspirin (325 mg). A bolos injection of 
lidocaine (75 tng) was followed by a continuous infusion. 
Sublingual isosorbide dinitrate (5 mg) and intravenous vera- 
pamil (5 mg) were administered unless contraindicated by 
hypotcnsion or bradycardia. 
In earienrs ommtina to ihe hosoiud nirh clinicrrl cnrdio- 
In the emeraencv room or on arrival in the cardiac 
balloon inflations were performed. Coronary angioplasty of 
noninfarct-related vessels with significant stenoses (P70% 
diameter stenosis) was deferred to later in the hospitaliza- 
tion. Successful angioplasty was defined as a residual lttmi- 
nsl diameter narrowing of ~40% without a major procedural 
complication (death or urgent bypass surgery). 
A&-r nnpiop$aty. he,mrin IWP rorrritwly ronrinwdfor 36 
IO 48 h. All patients were mimtained on aspirin (325 mg) 
three times daily, dipyridamole (75 mg) three times daily and 
an oral calcium channel blocker. Repeat catheterization was 
performed in patients with signs of recurrent ischemia (ex- 
ertional or rest angina. reinfarction evidenced by recurreni 
pain 230 min with reelevation of cardiac enzymes or angina 
or 21 mm ST depression. or both. during a submaximal 
exercise test) before discharge. In addition, predischarge 
angiography was performed in all consenting asymptomatic 
patients. 
Followup. Long-terns data were collected from clinic 
and telephone interviews. questionnaires and discussions 
with refertine ohvsicians. This infomtation was stored in a 
computer d&&e and updated periodically. The New York 
Heart Association functional cla:sificalion ofangina pectoris 
was recorded et the time of the latest follow-up evaluation. 
Statistics: Fisher’s exact test or chi-square analysis were 
used for cornprisons of categorical variables. The two- 
tailed Student’s r test was used for comparisons between 
Data analysis. End-systolic and end-diastolic frames 
from both the preangioplasty and follow-up ventriculograms 
were digitized using a Tektronic 4052 computer. Ventricula- 
continuous variables. Survival curves were generated using 
grams that were technically inadequate because of incom- 
plete apacification or ectopic rhythm were excluded from the 
the Kaplan-Meier method. Stepwise logistic regression anal- 
analysis. A modified Dodge area-lenglh method was used to 
calculate end-diastolic and end-systolic volumes and ejec- 
ysis was used to examine independent predictors of in- 
tion fraction. and regional wall motion was evaluated using a 
modification of the centerline chord method, dividing the 
hospital death and imorovement in left venlricular function. 
heart into I9 regions, as previously described (11.12). Im- 
proved regional wall motion was defined as an increase in the 
regional wall motion score by sl standard deviation in at 
least one semnent within the infarct zone. 
g&shock isystolic blood pres&e 580 mm Hg with 
clinical evidence of systemic hypopetfusion unresponsive to 
t&ids). an intraaortic balloon pump was placed before angi- 
ography. A single plane left ventriculogram was performed 
in the 30” right anterior oblique projection using 30 to 50 ml 
of contrast agent. Coronary arteriography was performed by 
first visualizing the suspected noninfarct-related vessel and 
then visualizing the infarct-related vessel. In the majority of 
patients, a 0.018 in. (0.046 cm) guide wire was used to cross 
the occluded infarct-related vesxl. An over the wire balloon 
catheter was then advanced across the lesion and multiple 
Factors analyzed inilcded gender. age, infarct location. 
infarct-related artery. total number of diseased vessels, 
cardiogenic shock. time to repafusion. left ventricular end- 
diastolic pressure. peak serum creatine kinase. presence of 
thrombun. presence of collateral vessels, angioplasty suc- 
cess or failure. patency at predischarge angiography and 
baseline ventricular function. 
Msltiwvimr nnrrlwi,~ of xsrviwl cwflfs war performed 
using Cox proportional hazard regression. In addition to the 
variables already listed. the preseoce or absence of complete 
revascularizstion at discharge, defined as no remaining ste- 
nosh ~50%. was considered. The subset of patients mee ing 
entry ctiieria for most thrombolytic lrials isgc ~75 years. no 
cardiogenic shock at presentation. no prior bypass surgery 
and treatment within 4 h of symptom onse~l was analyred 
separately for in-hospital death and long-lerm outcome. A p 
value <G.OS was considered significanl. 
ResuIts 
B~lilineclin~aadangiographiccharacteristics(Table II. 
The mean age of the 285 palients was 61 years and 71% Pew 
men. The mean iime from symptom onsel lo angioplasty was 
5.2 h: 58% of palienis were treawd within 4 h of pain onset 
and 80% were treated within 6 h. Cardiogenic bhock was 
present in33 patients(l2%). Only I01 patients (3Sr/,) met the 
usual entry criteria of man) thrombolylic trials (age 575 
years. no shock at presentation. no prior bypass surpry and 
w&ment within 4 h of pain onset). 
Two vessel coronary arlery disease was present m 163 
patients (57%) and three vessel disease in I?? patients (43%). 
In 32 patients (I I%), the infarct-r&cd vewl was a saphe- 
nous vein graft. 
Results of primary angio+ty. c’uronary angiopla~!y 
was s~cccssful in 2S6 19VX) of rhe 285 palien&. Success was 
ochievcd m I48 parienrs l92r/,l with IWO vessel disease and 
108 (SW) wilh three vessel &ease Ip = NS). Neither Ihe 
nalive vessel dilated nor [he clapsed lime from pain onset to 
reperfuvon altered the angioplasly sncccss rw. Successful 
reperfuwn was achieved in 16 181%‘rl of 32 saphenous vein 
grafts compared with 230 (91%) of 253 native coronary 
arteries Lp ‘: O.OlL 
Dwr,wr~~ b~pos~ rnrw.v was required in six patients 
(2%). including IWO patients wilh wo vessel disease and faur 
patient5 with three vessel disease (p = NS). An additional 
two patient\ wilh three vessel disease were referred in stable 
condition for elective bypass surgery within 24 h of dmis- 
sion. 
Hoapiml course (Table II. The overall in-hospital morlal- 
ity rate was 12% (33 dealhb in 285 palienls). T~erWwo 
deaihs EW) occurred among Ihe 256 palienrs with successful 
primary angioplasty compared whh 11 deaths 133%) among 
the 29 palienls in whom angioplasty had not been successful 
Ip < O.llf)l~. In-hospital death occurred in I3 (85% of 163 
patient> wilh IWO vessel disease and 20116%) of 122 palienls 
with three vessel dkase (a < O.D51. Death occurred in I5 
Wr/,l of 33 patients with cardiogenic shock and 18 of 252 
patients (WI without shock Ip < 0.001). Dealh occurred in 
‘4 (!4%1 of 59 patients 270 years old including I? of 50 
+ 
When the subsetbf patients who &entry criteri~ for most 
thrombolytic trials was considered. hospital mortality oc- 
curred in only 4% of patients (4 of 1011, including 2 (3%) of 
64 patients with two vessel disease and 2 (5%) of 37 patients 
with three vrssel disease (p = NSI. 
In descending order of importance. sniwrinle predictors 
of in-hospifnldcaolh included cardiogenic shock. left anterior 
descending afiery-related infarction. age 270 years and 
three vessel disease. Logistic regression analysis identified 
cardiogenic shock and age ~70 years as independent predic- 
tors of in-hospital death. Among the factors not indepen. 
dently associated with in-hospital death were time to rcpcr- 
fusion. infarct location. gender and number of diseased 
vessels. The interrelation amongcardiogenic shock. age 970 
years and number of diseased vcs~els in patients with 
in-hospital death is presented in Table 3. 
S!ro!w and myocardiul ruptrrw did nor ocw among I/W 
BS potienrs. Vascular complications, including retroperita. 
neal bleeding, vascular trauma requiring repair. and rcquirc- 
ment for transfusion, were seen in eight oatients 13%). 
Coronary rcoeclwion. Reocclurio~ otthe infarct-related 
artery during hospilalization was noted in 33 (18%) of the 181 
patients with p&discharge angiography. Reocclusion was 
symptomatic in I8 patients and ws found on routine fol- 
low-up angiography in I5 additional patients. In four ofthese 
patients. reocclusion was accompanied by reekvation of 
cardiac enzymes. If the 33 patients with reocclusion arc 
expressed as a percent of the total number of hospital 
survivors, the reocclusioo rate was 13%. Of the 33 patients 
with reocclusion of the infarct-related artery. 12 underwent 
successful repeat angioplasty. 2 had foronary bypass sur- 
gery, 2 died and I8 were treated medically. Therefore, of I8 I 
patierdr with angiographic follow-up study before discharge. 
162 (90%) were discharged with a patent or bypassed infarct- 
related vessel. An additional I6 oaients underwent elective 
coronary artery bypass surgery before discharge. 
Let? vcntrtrular function. Paired baseline and oredis- 
charge ventriculograms were available in I33 patic& (54% 
of hospital survivors). There were no significant differences 
between patients with compared with those without fol- 
low-up studies (Table 4). Left ventricular eiection fraction 
incrc&df-omS0.3 + 14.6rOto57.6 2 13.2%(p<O.WI)and 
increased 25% units in 77 oatients (57%). Left ventricular 
function improved roost in petienlspr&enting with moderate 
or severe leti ventricular impairment; in patients presenting 
with cardiagcnic shock, ejection fraction increased from 
24.8% to 38.1% (p < 0.01). 
Repionol wall maion improved in 59% of patients with 
repeat vcntriculography (79 of 135). Anterior myocardial 
infarcrion and sustained patcnfy of the infarct artery eorrc- 
lated independently with improvement in regional wall mo- 
tion. 
Late outcome (Fig. 1 to 4). Follow-up data were available 
in 251 (99%) of252 hospital survivors at a mean interval of35 
* I9 months. There were 31 late deaths and 221 patients 
were alive. The actuarial I year and 3 year survival rate was 
92% and 87%. respectively (Fig. I). The I and 3 year survival 
Figure 1. Kaplan.Meier actuarial survival curves after hospital 
discharw for patients tpts) with two twAtd ttm) and three (d&cd 
line) vcswl coronary anery discase. 
rate for patients with two vessel disease war YtG and YJC;. 
respectively. and 84% and 75%. respectively up < 0.0011. in 
patients with three vessel disease. .The I and 3 year wvwa~ 
rate in men (94% and 90%. respectively) was superior !o that 
in women (88% and 78%. respectively. p = n.Ol). The 
overall I and 3 year survival rate in the IO1 thrombolyric 
trial-equivalent patients was 9fG and 92%. rcspcctively. and 
was superior to that in patients not meeting these ebglbdlty 
criteria (Fig. 21. 
Cox multivariate analysis identified reduced (sJO%I 
baseline ejection fraction. female gender and cardiogcmc 
shock as factors independently related to late death. When 
long-lenn survival was analyzed for both the number of 
diseased coronary arteries and Ibe ~tatu~ of the left ventricle 
Figure 5. Aauarial survival curves ailcr hwpital discharge for 
pients wilh two vessel direare 0VDB and three vessel Cireare 
OVD) separated by a baseline MI ventrieulareje&m fnman IEFl 
of XC@ or +iO%, Numben in pnnnlhcsees Indicate the ealicnls in 
each subgroup ~1 hospitrl dixhargr. 
bypars wgery as ewa. the overall actuarial I and 3 year 
event-free wvival rare wa~Xff? and ?\a. respcaivcly. For 
patienb ~ilh two vessel daeaz. the event-free survival rate 
wn XK+ and 82%. resorctivcly. compared wlh 68% and 
Discussion 
Mul~~x~rel coronary artery disease is found in the ma- 
jority of wrvivors of acute myocardial infarction (l-6). 
Although the contemporary natural history of these patients 
15 nor fully known. the number of diseased vessels has been 
shown ID be an impmtanl predictcr of subsequent survival in 
patent\ treated conservatively in longitudinal studies (2.4- 
81. Roubm et al. (5) followed up 229 hospital survivors <6! 
ycarr of afir for a mean period of 24 months. The survival 
rate a I year was Y9%. 92% and 85% in patients with one. 
IWO and three vessel disease. respectively (p < O.OOSI. In 
other \tudiex 18). the number of diseased vessels also pre- 
dicted recurrent myocardial infarction. Therefore. patients 
with muhivesrel disease and myocardial infarclion can be 
considered d high risk group. m which effective reperfusion 
aagic\ mghl be anticipated to yield Ihe greatest benefit. 
To date. the results of acUe reperfurion Ihempy for myo- 
cardial infarction in oatients with multivessel coronor~ ar- In the present series. the infarct-relaled vessel in 32 
tery disease have not been emphasized. 
Rationale for direct aneiorlaatr. The aporoach that we 
have employed for nearly alI &ots with&e myocardial 
infarction since 1981 has been direct coronary ansioplasty 
without antecedent thrombolytic therapy. Indeed. in 1988. 
%% of patientr with evolving myocardial infarction accom- 
panied by ST segment elevation seen by us within 6 h of pain 
onset or with continuing evidence of myocardial &hernia 
were treated with emergency direct angioplarty (I I). Direct 
angioplasty offers several potential advantages over reperfu- 
sion with thrombolytic agents. including I) the potential to 
surpass the approximat:Z% reperfusion plateau for acute 
infarct-related vessel patency observed with pharmacologic 
interventions (13.14): 2t relief of the underlying stenosis in 
the infarct-related vessel. which may lead to greater recov- 
ery of regional myocardiai function and lessen the incidence 
of recurrent ischemic events compared with thmmholytic 
egents alone (15-17); 3) avoidance of hemorrhagic compli- 
cations and transfw;-, requirements associated with throm- 
holytic agents. including a 0.5% to 1.0% incidence of stroke 
(18); and 4) the ability to otTer repelfusion therapy to many 
patients normally excluded from tbrombolytic therapy in- 
cluding the elderly. those with hypertension. those in cardiac 
shock. lhose with prior bypass surgery and those with recent 
invasive procedures or cardiopulmonary resuscitation 
ll9.20). The broad applicability of direc! angioplasty in the 
therapy for acute myocardial infarction is highlighted in the 
present study by the inclusion of 59 patients 170 years old. 
33 patients in cardiogenic shock and 45 patients with prior 
bvoass sur~ew. Indeed. ODIY 101 oatients (35%) met the 
e&y criteria of many thrombolytic;rials (19.20). 
Ittfaret.relsled vessel pa*eney. Overall, 90% of infarct- 
related vessels in patients with multivessel disease were 
successfully dilated to ~40% diameter narrowing with direct 
coronary angioplasty. Although these wults are less than 
the 99% success rate we achieved with direct infarct-related 
angioplasty in 215 patients with one ~vessel disease (12). they 
compare favorably with the previously reported reperfusion 
rates of 69% to 909, using anaioolastv in acute mvocardial 
infarction for pooled patients with .one and m;ltivessel 
disease (17.21-24). In our series. the orocedural success 
rates were equivalent for patients with t&o and three vessel 
disease (92% and 88%, respectively). These results differ 
from those of Ellis et al. (24) in 300 patients with acute 
myocardial infarction treated with coronary angioplarty. in 
which the presence of three vessel disease was found to be a 
major predictor of ?.ngioplasty failure. Indeed. in their study 
(24). angioplasty was successful in only 56% of patients with 
three vessel disease and absent anterograde coronary flow. 
This difference may pxtially represent the adverse effect of 
prior thrombolytic therapy, especially tissue plasminogen 
activator given to 54% of their patients. on the subsequent 
resulls oi acute coronary angioplasty. 
patients v&s a saphenous vein graft. and success was 
achieved in only 81% (p < 0.01 compared with native 
infarct-r&ted arteries). This may reflect the greater burden 
of thromhus present in vein grafts and the propensity for 
more diffuse disease involving aid grafts. Becane the effi- 
cacy of thromholvtic theraw in oatieats with ooor results of 
by&s wrgery is unknown as a result of e&lusions from 
major rhrombolytic trinls (19.20). the acceptable success rate 
with direct angioplasty indicates thar prior bypass surgery 
should not preclude cute reperfusion by mechanical means. 
Iwhcspital death. lo-hospital death in the present series 
of patients with multivessel coronary artery disease oc- 
curred in 33 (12%) of 285 patients and was significantly 
bigher than in our experience with patients with one vessel 
disease (3 [I%] of215 patients; p c: 0.01) previously reported 
(121. This was likely a result of older patient age (61 versw 
56 years). frequency of cardiogertic shock (12% versus 3%) 
and poor vent&ular function Lo the group with multivessel 
disease. The 12% mortalitv rate in oatients with multivessel 
disease compares favorably with ihe overall II% to 20% 
mortality rate in historic control series (25) of patients 
treated with conservative therapy. even though these studies 
undoubtedly included substantial percents of lower risk 
patients with one vessel disease. Of note. the in-hospital 
mortality rate in the subgroup of patients meeting the entry 
criteria ofmany thromholytic trials was only 4%. This can be 
compared f&ably with-a preliminary report (26) of a 12% 
in.hospital mortality rate in patients with multivessel disease 
eligible for and receiving thrombolytic therapy. Subset anal. 
yses of the larger thrombvlytic trials are needed to examine 
further the comparable eficacy of these agents in patients 
with multivesscl disease. 
La&k re~re.ssion analysis idmdjed only the pmsmce 
of cmdiogenic shod and o.w a70 yews IIS si&Tcmf 
indqxndenf predictors of hospital death. The resulls in 
patients with multivessei disease and shock are noteworthy. 
with a survival rate of 55% in these patients. This outcome is 
superior to the expected natural history in this group and is 
consistent with reports (27) of improved sunival with acute 
coronary angioplasty. The impact of advanced age on the 
outcome of direct aneioolastv in acute mvocardial infarction 
has been emphasizeh previously by l-ioliattd et al. (28). 
although the mortality rate of 24% (14 of 59) in the present 
series is somewhat more favorable than the 34% they ab- 
served. Although not an independent predictor of iwhospitnl 
death, the number of diseased vessels was related to hospital 
outcome with 16% of patients with three vessel disease and 
8% of those with two vessel disease dying in hospital (p < 
0.05). 
Myoeardial salvage. The improvement in global and re- 
gional wall motion demonstrated in >50% of the patients 
with paired angiographic studies in this series is similar to 
previous reports (15.22) of direct angioplasty for acute 
infarction and is greater than the mcrcd~c nolcd in mo\t a~~mpromauc p.&ntc declined predixharge invasive wd- 
thrombolytic trials (18) reporling information on ventricular ie,. pared vcntrudognphy and coronary anglography were 
function. Previous studies (15.17) have indicaled that relief ev:dl;~ble in only a rubset of patients. Unintcnlional ~elc~~io~~ 
of the underlying stenosis ir. Ihe infilrct zone wdh coronx~ bra* in the\e patientr may have had an impacl on the result5 
ang~oplasty results in greater recovery of regmnal *illI reported and make definite conclusions about vcotriculx 
motion than occurs with thrombolytic therapy ;rlonc. salvage and rcocclusion 1~x5 difficult. 
Longterm outcome. Overall. p&cot\ ii!h multivcwcl Conrluaions. It i\ clear from rhi\ \tudf and arher~ lhar 
disease treated with direct angioplasty had a I and 3 year dirccl .~n~wpla\ty is a very cffcctive mcao~ of achicwng 
survival rate of92Q and 87%. respectively. The independem early infarct-related vessel patency after acole myocardizzl 
predictors of survival Ishock. female gender and reduced mfxclion. wth reperfusion rate5 of z9V%. Fur!hermorc. 
ventricular function) are similar to those ldent&d by Stack patient rafcty i\ excellent. with infrequent bleeding and no 
et al. (29). As with Conservative therapy of myocardial incrcawd ri\k of cerebrovascular accident. The perception 
infarction (2.4-8). the number of di\eored vec\els wa< ha5 been that this approach is Impractical for roost patients 
related to survival after direct coronary angiopla~ The I hecaucc of rhe cxccwivc lime requtred to arrive at ao 
and 3 year survival rote of 98% and 94%. respectively. for angioplarty ccntcr. Challenging this notion is II recent anal- 
patients with two vessel disease is excellent and IS not y*ic of the population chancteris~ics of the ccntinenlal 
significantly different from our experience in those wilh one United Stale* (JOI revealmg that 63% of citizens live within 
vessel disease (I I, 12). This is in kecpmg wdh reports l?!.?9) 30 mn. R3V within 50 min and 93% within 90 loin of an 
demonswatine encellcnt lone-term sorvivnl oiler ocqrcssivc anqioolasty center. __ 
methods to establish and maintain infarct-r&led VCZICI -P&cot; with mult~vcsscl disease and evolvmg myocar- 
patency before hospital dijLharge. Thege benefits may he dtal infawion arc at increased risk uf complications. Al- 
independent of myocardial salvage (30) and may include though the oplimal reperfurion Wategy in these patients has 
prevention of ventricular dilation and lethal arrhythmias not been raolwd. this study demonstrates that direct coro- 
(31-33). nary angioplasty without anlecederd lhrombalytic therapy 
Long-term survival was markedly reduced I” patients citn he performed wilh a high vessel patency rate and few 
with three vessel disease and par lef: venlricular funcllon procedure1 complications. Shorl- and long-term survival 
(5% at 4 years1 after acute infarction intervcn~ion (Fig. 31. rates compare favorably with those associated with cooscrv- 
These results appear to compare favorably. however. with ~uvc or lhrombolylic strategies. Future investigationsaimed 
the 42% 4 year survival rate in medically treated patients at ldcntifying methods of further improving long-term SW- 
with similar anatomy (32). ~viv~l in the high risk palienls after succcssiul reperfurion 
The oprimol predischarge mnnnmwnr I~U~YSY Ji~r pa- may confirm the benefit conferred by early direct coronary 
tients wirh mnlrivessef disruw R//PI rrrr~e~ssJul in/m+ angioplasty. 
related mgioplasty is ancmoin. In agreement with a rcccot 
majorlrial ofthrombolytic therapy 119). our data suppart the 
infrcqucnt use of predischargc procedures in paiienls wilh Eeferences 
two vessel disease irrespective of left ventricular function 
and in patients with three vessel disease with goad ventric- 
ular function in !he absence of accepted indications such as 
pastinfarction angina or left main coronary artery disease. 
Survival in patients with three vessel disease nod poor left 
vcn~riculariunction is diminished. and nonrandomized stud- 
ies W-38) in patients after acute infarction suggest that ao 
1 Bcmu~.Cr~merA. SanzGA.etrl. nwgnphicfindmgr I mnnlhtincr 
mywar&., in,.lrc,ion: P prmpaive Iludy 01x9 s”NIVorx. Circ”ldd0” 
aggressive approach including complete rcvascularization 
before discharge may lead to improved long-term wnival. 
Data from the Coronary Artery Surgery Study IChSSl (391 
also support surgical rcvascularization in the subgroup of 
patients with three vessel disease and poor left ventricular 
function. 
Study limilalions. Trealment was not randomized and the 
analysis is retrospcclivc. Furthermore, Lhc results reflect the 
work of a single group uf experienced iotcrvcotiooal cardi- 
ologists. Firm conclusions regarding comparisons between 
direct angioplasty and other means of myocardial reperfu- 
sion must await the results of ongoing trials. Because many 
1096 KAHN ET AL. JACC “0,. Ih, No 5 
INFARCT ANGIOPLASTY ,N M”LTIYESS~,. DlSEASE NwErllhCr I, ,5slII(LRYJ)(r 
II. O‘Kccfc JH Jr. Ruihelrord BD. M&m&y DR. LI al E&y and Isle 
rcwllr of coronary angioplasly without antecedent thmmbolytic lherapy 
lnr acute myocardml infawian. Am J Cardml 198Y:W:l??l-30. 
12. Stone GW. Ralherfwd BD. McConahay DR. d al. Dirccl coronary 
angiopbty in acul? myacardial inlarction: oulcome in par~cnlr with 
single ver=.el dircarc. J Am Coil Cardial 1989:15534-43. 
13. Topal EJ. Califf RM. George BS. Kcreiukcs 01. Lee KL. lnri8hlsderived 
from the Thmmbolyrir and Angioplasly m &xx&al lnfarclion (TAMI) 
trial>. J Am Call Car&l 19@~3:12lruppl Al:24A-3IA. 
14. Topol FJ. Coronary ~l8ioplarly fnr awe myocsrdial iafxclion. Ann 
lnlcm Med 1%8:109:970-80. 
15. O‘Neill WO. Timmis GC. Bourdillon PD. et al. A pmrpeclive randomized 
clinical lnal of inlracoronary nreptokinare v* comrwry an8iupb1rly Fnr 
acute myowrdial infarction. N Engt J Med 1986L114:812-8. 
16. Fung AY. Lai P. Topl U. et al. Value of percumneour lnosluminal 
coronary angioplasty aflcr unwccrrful rlreplokinase therapy in acur 
myocardial infarclion. Am J Cardiol I9#~5B:#6-91. 
17. Erbel R. Pop T. Diefenbach C. Meyer 1. Lone-len resulu of Ihmm- 
bulylic therap) wlh and wilhoul percutaneous lmnslum~nal coronary 
nngioplasly. J Am Coil Csrdiol 198??14:276-85. 
18. Calms JA. Collins R. Fuster V. Parramani ER. Coronary Ihrombolyrir. 
Chest 1989.95:73%87s. 
19. The TIblI Sludy Group. Comparisun of inwive and conscwalive sm+~. 
rgier tier Ir~ahntnl wnh in!ravenouL liaue plawninogen acliwor in 
acule myocardial Infarction. N Engl J bled 1989:320:618-27. 
2U Top01 EJ. CaliRRM. George 85. e! al. A randomized I&I of immcdiale 
versus delayed elecwe angiaplarty aner iolravenour &rue plasmpo8en 
ilclivatar in acute myoca&l inlarction. N En@ J Med 1987:317:581-K. 
21. Ellis SC. D’Neill WO. Bulcr ER. el al. Impliculion! ior pawnl triage Tmm 
wwal and IelI ventricular funcbonal recwery undybis in SW palienlr 
frcatcd wllh Corowry angioplwly for acuR myocardial inlarclion. J Am 
Cull Cardiol 1989:13:1251-9 
22. Rothbaum DA. Linncmeier TJ. Landin RI. et al. Emer8ency percuune- 
w transluminal coronary angioplarly in srule mywrdlal infarction: il3 
year experience. J Am Call Car&al 1987:10.261-72. 
23. Slack RS. O’Connor CM. &cark DB. et al. Corovwy ~rlur,ob during 
BcuIe myacardial infarclion with a combined !hcmpy of romnav an&. 
Plariy and h@b~dore bnmdycnuus slreplakmze. Circulalion 1981:77:151- ,. 
35. 
26. 
27. 
23. 
29. 
IO. 
31. 
32. 
33. 
34. 
35. 
36. 
an8iophny wformcd for xue mywardial inlarclion. J Am Coil Car&al 
1988:1?‘1407-15. 
The Mulliccnlcr Porlinlarctmn Research Group. Risk xlratlhcatfon and 
survival alter myocnrdial inlrclian. N En81 J Med 1983:309:331-6. 
camnaryanrry dlrcaleand‘thcremotelanein’the reperfusionerd(ahrtr). 
I Am Call Cardml 1%9:131auppl Ah92A. 
Lee L. Bales ER. Pill B. W&on JA. LnuRr N. O’Ncill WW. Rrcula- 
Holland KJ. O’Ncill WW. Bales ER. Pill B. To@ EJ Emergency 
percutanrour~r;mslumilal~~8ioplw1y during xute myaardial inlwxion 
for paliemr mow Ihan 70 years ofage. Am J Cardml 1989;63:3%493. 
Slack RS. Califl RM. Hinohara T. LI al. Survival and tardiicevent rater 
in the firs1 year allFr emergency camwy angioplaJ!y for awe myaar- 
dial infarclion. J Am Colt Csrdial IY8R:I I:1 141-9. 
Cigarroa RF. Law RA. Hillir LD Pmgnorir aRer aculc myocardiil 
infamion in PUcnr with ilnd wilhoul residual anlrgnde coronary bkwd 
flow Am J Cardial 1989:M:I55-M. 
Warren SE. Royal HD. Markir JE. Fmssman W. McKay RG. Time 
couc of kft vcnlneulardilalionaRer myartrdial iokuclion: influenccof 
infarct-related ancry and success af coronary Ihramtmlysis. 3 Am Coil 
Cardiol 1988:11:129. 
Malt MB. Riepqwsr I. Fisher LD. el ~1. Survival ol medically waled 
paliena in the Coro~ry Anet{ Surgery Study (CASSI Rtgirlry. Circu- 
Ialion 1982;6%562-8. 
Kcnrchor LE. Eru& P. Rwntol M. CI al. E@XIS alearly rcpe&ion 
!n atule myocardial inlarclion on arrhylhmiar induced by programmed 
!limulalion: a pmspeclive. randomized study. I Am Coil Cardiol 1986:7: 
1234-42. 
Pelrawch JA. Schmider JA. Taylor G. e1 al. Ewly and law results of 
operalion after lbrombolylic therapy far acute myoeardiel infuc6m. 
J Thorac Cardiovarc Surg 198&92:853-8. 
Mrssmer BJ. Uebir R. Rieger C. Minale C. Hols!adln F. Effcn S. Late 
rewlll aRa inlnclronary Ihromlmlysir and early bypass g&in8 Tar 
aculc myocardial infarclian. J Thorac Cardiovax Surs 1989:97:10-g. 
Salem BI. Gowda S. Kaikal h:. Lcidenlmst R. Cox JL. Wrg~l~nT~ Early 
pcrcularcwr tmruluminal corowry angiopl:#rly olwmnary bypass SUP 
gew following lhrombolytic trellment of acwe mytiial inluraion. 
Chest 1%1:91:6#8-S3. 
MtyerJ. Men W. DOrrR.d al. Scquenli.l intervention prc&urcsaf~er 
inlrdcomnaw rhrombalyris: h&cm dilation. hypasr surgery. and medical 
Irealmenl. Int J Canliol 1485:7:281-93. 
Bhifcld W. Thmmbdyris in acute myocardial itiuclion aml rhc indica- 
lirm lor aonocomnxy bypss surbwy. Adv Cudirl 1988;36:16>73. 
Rsramani E. David KJJ. Gilt&c MJ. Killin T. A randomized trial of 
24. Ellla SG. Top01 EJ. Gallirnn L. ei II Predicton ol success lor coronary 
40. 7-S Arwalcr. Mrlhmfology of Ihe PICA analysis. Angiopbrry Tojay 
1911w:3. 
